Healthcare & Life Sciences
ArriVent
United Statesarrivent.com
ArriVent is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 3 tracked investors.
activeseries-b
series-b
Stage
2020
Founded
3
Investors
About ArriVent
Based in the United States, ArriVent is a startup founded in 2020. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
ArriVent is a clinical-stage biopharmaceutical company focused on the global development of innovative cancer therapies, particularly targeting EGFR mutations in non-small cell lung cancer through its lead drug firmonertinib.
Explore ArriVent's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.